<!DOCTYPE HTML>

<html>
	<head>
		<title>Pharmaceutical Industry in China</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
	</head>
	<body class="is-preload">

		<!-- Wrapper -->
			<div id="wrapper">

				<!-- Main -->
					<div id="main">
						<div class="inner">

							<!-- Header -->
					

							<!-- Content -->
								<section>
									<header class="main">
										<h1 id="h1 top">Industrial Jargon</h1>
									</header>

									<span class="image main"><img src="images/cover.gif" alt="" /></span>



									<hr class="major" />
									<h2 id="ij1">Industrial Jargon</h2>


										<div class="table-wrapper">
														<table class="alt">
															<thead>
																<tr>
																	<th>Name</th>
																	<th>Description</th>
																	
																</tr>
															</thead>
															<tbody>
																<tr>
																	<td>Alternative medicines(s)</td>
																	<td>Alternative medicines which are selected by the bid evaluation committee of local government </td>
																	
																</tr>
																<tr>
																	<td>Awareness rate </td>
																	<td>The proportion of people among those with the disease who had previously been diagnosed by a medical practitioner </td>
																	
																</tr>
																<tr>
																	<td>Capsule(s) </td>
																	<td>A solid dosage form in which medicine is enclosed in a hard or soft soluble container, usually in a form of gelatin </td>
																	
																</tr>
																<tr>
																	<td>Chemical medicines </td>
																	<td>Medicines created by means of chemistry or obtained by chemical processes </td>
																	
																</tr>
																<tr>
																	<td>Chronic kidney disease </td>
																	<td>The slow loss of kidney function over time </td>
																	
																</tr>

																<tr>
																	<td>Chronic kidney failure </td>
																	<td>When the kidney is severely impaired and almost non- functionable to keep the person alive </td>
																	
																</tr>
																<tr>
																	<td>Class I hospitals </td>
																	<td>Local hospitals with small capacity designated as class I hospitals by the Ministry of Health hospital classification system that provide one community with elementary medical services  </td>
																	
																</tr>
																<tr>
																	<td>Class II hospitals </td>
																	<td>Regional hospitals with minimum capacity designated as class II hospitals by the Ministry of Health hospital classification system that provide multiple communities with integrated medical services and undertake certain educational and scientific research missions </td>
																	
																</tr>
																<tr>
																	<td>Chemical medicines </td>
																	<td>Medicines created by means of chemistry or obtained by chemical processes </td>
																	
																</tr>
																<tr>
																	<td>Class III hospitals </td>
																	<td>Multi-regional hospitals with large capacity designated as class III hospitals by the Ministry of Health hospital classification system that provide multiple regions with high quality professional medical services, undertake higher education and scientific research initiatives and are followed by lower ranked Class II and Class I hospitals </td>
																	
																</tr>
																<tr>
																	<td>CT</td>
																	<td>Computer tomography, an imaging method that uses x-rays to produce a detailed picture of a cross-section of the body </td>
																	
																</tr>
																<tr>
																	<td>Dialysis </td>
																	<td>D process of cleansing the blood by passing it through a special device. It is necessary when the kidney is not able to filter the blood  </td>
																	
																</tr>
																<tr>
																	<td>Evidence-based practice</td>
																	<td>The use of mathematical estimates of the risk of benefit and harm, derived from high-quality research on population samples, to inform clinical decision-making in the diagnosis, investigation or management of individual patients  </td>
																	
																</tr>
																<tr>
																	<td>“GAP” or “Good Agricultural Practices”  </td>
																	<td>Good Agricultural Practices, which are guidelines that describe the general principles and provide technical details for the cultivation of medicinal plants. They also describe quality control measures  </td>
																	
																</tr>
																<tr>
																	<td>“Generic Medicines” </td>
																	<td>Medicines which have been launched in the PRC, being those medicines other than the New Medicines </td>
																	
																</tr>
																<tr>
																	<td>“GMP” or “Good Manufacturing Practices” </td>
																	<td>Good Manufacturing Practices, which are guidelines and regulations issued to ensure that pharmaceutical products within those guidelines and regulations are consistently produced and controlled to the quality and standards appropriate for their intended use </td>
																	
																</tr>
																<tr>
																	<td>Granule(s)</td>
																	<td>A form in which medicines may be delivered for oral ingestion, produced by missing extracted active medicinal ingredients with supplemental materials or powdered medicines which are formed into dry granules  </td>
																	
																</tr>
																<tr>
																	<td>“GSP” or “Good Supply Practice” </td>
																	<td>
 
Good Supply Practices, which are guidelines and regulations issued as part of quality assurance to ensure that pharmaceutical distribution enterprises distribute pharmaceutical products in compliance with those guidelines and regulations </td>
																	
																</tr>
																<tr>
																	<td>High throughput screening </td>
																	<td>A technology that employs automation and robotics to conduct thousands of biological assay experiments within a short period of time and can be used to screen potential medicine candidates  </td>
																	
																</tr>
																<tr>
																	<td>“iu” </td>
																	<td>International unit, a unit of measurement for the amount of a substance, based on biological activity or effect </td>
																	
																</tr>
																<tr>
																	<td>Medical institutions</td>
																	<td>Institutions created for the practice of medicine, and for the purpose of this prospectus, exclude hospitals  </td>
																	
																</tr>
																<tr>
																	<td>New Medicines</td>
																	<td>Medicines which have never been launched in the PRC market previously as defined under the Registration Measures </td>
																	
																</tr>
																<tr>
																	<td>Oral solution </td>
																	<td>A form of medicine in which medicine is dissolved in a liquid and to be taken orally </td>
																	
																</tr>
																<tr>
																	<td>Prescription medicine(s)</td>
																	<td>Medicines which may be prescribed only by qualified medical practitioners  </td>
																	
																</tr>
																<tr>
																	<td>Prevalence rate </td>
																	<td>The proportion of people in a population who have a particular disease at a specified point in time, or over a specified period of time  </td>
																	
																</tr>


<tr>
																	<td>
“Registration Measures” </td>
																	<td>Measures on the Administration of Pharmaceutical Products Registration (理 ), promulgated by the CFDA on 10 July 2007 and effective from 1 October 2007  </td>
																	
																</tr>
																<tr>
																	<td>Retail price </td>
																	<td>
The price at which pharmaceutical products are sold to the end users </td>
																	
																</tr>
																<tr>
																	<td>Soft capsule(s)</td>
																	<td>A form in which medicines are produced by mixing extracted active medicinal ingredients with supplemental materials so as to achieve uniform concentration of medicinal ingredients, which are sealed in a soft gelatine capsule  </td>
																	
																</tr>
																<tr>
																	<td>Successful bidding price  </td>
																	<td>The successful bidding price at which non-profit-making hospitals and other non-profit-making medical institutions purchase the pharmaceutical products selected at the collective statutory tender process  </td>
																	
																</tr>
																<tr>
																	<td>Tablet(s)</td>
																	<td>Dose of medicine in the form of a small pellets  </td>
																	
																</tr>
																<tr>
																	<td>Western medicines </td>
																	<td>Encompasses a range of medicines theories and practices evolved to maintain and restore human health, including diagnosis and treatments derived from dissection, microscopic analysis and chemical derivation, other than Chinese medicines 
 
</td>
																	
																</tr>
																<tr>
																	<td>Wholesale price </td>
																	<td>The price at which pharmaceutical manufacturers sell their pharmaceutical products to distributors, hospitals, medical institutions or pharmacies </td>
																	
																</tr>
																

															</tbody>
															
														</table>
													</div>
<h2 id="ij2">Interesting Video</h2>
<h3>Generic Vs Branded Drugs</h3>
<p style="text-align: justify">There are a lot of myths and misconceptions surrounding Generic Drugs. This infographic is created by MHC Asia Group for MHC Medical Network to educate its clients and help them make informed decisions.</p>
<center><iframe width="560" height="315" src="https://www.youtube.com/embed/_NJTKDHJw7Y" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe></center>

								</section>
								<section>
									<header class="major">
										<h2>Analysis</h2>
									</header>
									<div class="posts">
										<article>
											<a href="io.html" class="image"><img src="images/cover.png" alt="" /></a>
											<h3>Industry Overview</h3>
											<p>Customer Segmentation | Overview of China Healthcare Industry | Overview of China Drug Industry</p>
											<ul class="actions">
												<li><a href="io.html" class="button primary">More</a></li>
											</ul>
										</article>
										<article>
											<a href="icv.html" class="image"><img src="images/ivc_c.jpg" alt="" /></a>
											<h3>Industry Value Chain</h3>
											<p>The Life of a Drug | 
												Demystifying R&D + Drug Registration | 
												Supply Chain and Major Players (Competitive Landscape) </p>
											<ul class="actions">
												<li><a href="ivc.html" class=" button primary">More</a></li>
											</ul>
										</article>
										<article>
											<a href="sf.html" class="image"><img src="images/sf_c.jpg" alt="" /></a>
											<h3>Success Factor</h3>
											<p>Policy & Regulation Support | 
												Distribution Channel</p>
											<ul class="actions">
												<li><a href="sf.html" class="primary button">More</a></li>
											</ul>
										</article>
										
										<article>
											<a href="cs.html" class="image"><img src="images/cs_c.jpg" alt="" /></a>
											<h3>Case Study</h3>
											<p>Company 1 - Sino | Company 2 - Henrui</p>
											<ul class="actions">
												<li><a href="cs.html" class="primary button">More</a></li>
											</ul>
										</article>
										<article>
											<a href="ft.html" class="image"><img src="images/ft_c.jpg" alt="" /></a>
											<h3>Future Trend</h3>
											<p>Regulatory and Policy: Centralized Procurement | National Reimbursement Drug List (NRDL)</p>
											<ul class="actions">
												<li><a href="ft.html" class="primary button">More</a></li>
											</ul>
										</article>
										<article>
											<a href="ij.html" class="image"><img src="images/ij_c.jpg" alt="" /></a>
											<h3>Glossary</h3>
											<p>Industrial Jardon | Interesting Video</p>
											
											<ul class="actions">
												<li><a href="ij.html" class=" primary button">More</a></li>
											</ul>
										</article>
									</div>
								</section>

						</div>
					</div>

				<!-- Sidebar -->
					<div id="sidebar">
						<div class="inner">

							<!-- Menu -->
								<nav id="menu">
									<header class="major">
										<h2>Menu</h2>
									</header>
									<ul>
										<li><a href="index.html#h1">Homepage</a></li>
										<li>
											<span class="opener">Industry Overview</span>
											<ul>
												<li><a href="io.html#io1">Custom Segmentation</a></li>
												<li><a href="io.html#io3">Overview of China Healthcare Industry</a></li>
												<li><a href="io.html#io4">Overview of China Drug Industry</a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Industry Value Chain</span>
											<ul>
												<li><a href="ivc.html#ivc1">The Life of a Drug</a></li>
												<li><a href="ivc.html#ivc2">Demystifying R&D + Drug Registration</a></li>
												<li><a href="ivc.html#ivc3">Supply Chain and Major Players </a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Success Factor</span>
											<ul>
												
												<li><a href="sf.html#sf1">Policy & Regulation Support</a></li>
												<li><a href="sf.html#sf2">Distribution Channel</a></li>
											</ul>
										</li>
										

										<li>
											<span class="opener">Future Trend</span>
											<ul>
												<li><a href="ft.html#ft1">Regulatory and Policy: <br/>Centralized Procurement </a></li>
												<li><a href="ft.html#ft2">National Reimbursement Drug List (NRDL)</a></li>
											</ul>
										</li>
										
										<li>
											<span class="opener">Case Study </span>
											<ul>
												<li><a href="cs.html#c1">Company 1 - Sino</a></li>
												<li><a href="cs.html#c2">Company 2 - Henrui</a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Glossary </span>
											<ul>
												<li><a href="ij.html#ij1">Industrial Jardon</a></li>
												<li><a href="ij.html#ij2">Interesting Video</a></li>
											</ul>
										</li>
									</ul>
								</nav>

							<!-- Section -->
							
								<section>
									<header class="major">
										<h2>Latest News</h2>
									</header>
									<div class="mini-posts">
										<article>
											<a target="_blank" href="https://www.economist.com/business/2019/09/28/chinas-pharmaceuticals-industry-is-growing-up" class="image"><img src="images/n1.jpg" alt="" /></a>
											<p>The Economist - China’s pharmaceuticals industry is growing up </li></p>
										</article>
										<article>
											<a target="_blank" href="https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/chinese-growth-shots-some-years-away-for-pharma-companies/articleshow/71513734.cms" class="image"><img src="images/n2.jpg" alt="" /></a>
											<p>The Economic Times - Chinese growth shot’s some years away for pharma companies </p>
										</article>
										<article>
											<a target="_blank" href="https://www.chinadaily.com.cn/a/201908/14/WS5d536f5ea310cf3e35565a93.html" class="image"><img src="images/n3.jpg" alt="" /></a>
											<p>China Daliy - Pharma companies undergoing critical transformation</p>
										</article>
										<article>
											<a target="_blank" href="https://www.pharmaceutical-technology.com/comment/china-pharmaceutical-industry-2019/" class="image"><img src="images/n4.jpg" alt="" /></a>
											<p>Pharmaceutical Technology - Characterising Eastern China’s pharmaceutical manufacturing market: Shandong and Jiangsu</li></p>
										</article>
										<article>
											<a target="_blank" href="https://www.expresspharma.in/cover-story/is-china-the-next-land-of-opportunity/" class="image"><img src="images/n5.jpg" alt="" /></a>
											<p>Express Pharma - Is China the next land of opportunity? </p>
										</article>
										
									</div>
									
								</section>

							<!-- Section -->
							
								<section>
									<header class="major">
										<h2>Get in touch</h2>
									</header>
							
									<ul class="contact">
										<li class="icon solid fa-envelope"><a href="mailto:haa300.2019@gmail.com">haa300.2019@gmail.com</a></li>
									
									</ul>
									
										<h2 class="major"><a href="#top">Back to Top</a></h2>
								

							<!-- Footer -->
								<footer id="footer">
									<p class="copyright">&copy; Untitled. All rights reserved. <br/> Edited by GROUP E @ Fall 2020 - GBUS3030
										<br/> Nov 28, 2019</p>
								</footer>
								
						</div>
					</div>

			</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>